TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1930618

Group type: EXPERIMENTAL
Intervention: Biperiden 4 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Biperiden 6 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (Group REM-P)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Biperiden (Group REM-Bip)
Number of subjects: 26
Study: 7049075

Group type: EXPERIMENTAL
Intervention: Topical poly(ICLC)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 31335937

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All protein targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Without consideration of the protein targets
Number of subjects: 0
Study: 31698659

Group type: EXPERIMENTAL
Intervention: AFO (Ankle-Foot Orthosis) fabricated using material PA12
Number of subjects: 12

Group type: COMPARATOR
Intervention: No AFO (Control)
Number of subjects: 12
Study: 26548697

Group type: EXPERIMENTAL
Intervention: Balloon Sinuplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncinectomy
Number of subjects: 0
Study: 25079920

Group type: EXPERIMENTAL
Intervention: Best Practice Care (BPC)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Motivational Interviewing (MI)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Overall recall
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Parental ratings of usefulness of information
Number of subjects: 271
Study: 22271474

Group type: EXPERIMENTAL
Intervention: T-BEP (paclitaxel-bleomycin, etoposide, and cisplatin)
Number of subjects: 337

Group type: COMPARATOR
Intervention: BEP (bleomycin, etoposide, and cisplatin)
Number of subjects: 337
Study: 20391735

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 mg/kg and Propofol 2 mg/kg (group PRO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fentanyl 2 mg/kg and Sevoflurane 5% in a 1:2 mixture of oxygen and nitrous oxide (group SEVO)
Number of subjects: 30
Study: 18165765

Group type: EXPERIMENTAL
Intervention: Subcutaneous alemtuzumab (30 mg doses on days 0 and 1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Subcutaneous alemtuzumab
Number of subjects: 21
Study: 15226321

Group type: EXPERIMENTAL
Intervention: docetaxel plus thalidomide 200 mg orally each day
Number of subjects: 75

Group type: COMPARATOR
Intervention: docetaxel 30 mg/m(2) intravenously every week for 3 consecutive weeks
Number of subjects: 75
Study: 11566519

Group type: EXPERIMENTAL
Intervention: LEC removal from the nasal half (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LEC removal from the entire anterior capsule (Group C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No LEC removal (Group A)
Number of subjects: 60
Study: 9631312

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg bid for 4 weeks plus amoxicillin 500 mg qid for 2 weeks
Number of subjects: 229

Group type: COMPARATOR
Intervention: RBC 400 mg bid for 4 weeks and placebo qid for 2 weeks
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo bid for 4 weeks and amoxicillin 500 mg qid for 2 weeks
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo bid for 4 weeks and placebo qid for 2 weeks
Number of subjects: 229
Study: 7524591

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 30276799

Group type: EXPERIMENTAL
Intervention: Enhanced support methods (phone calls, text messages, Facebook, email) to encourage medical check-ups
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 53
Study: 28673304

Group type: EXPERIMENTAL
Intervention: French version of the query builder
Number of subjects: 42

Group type: COMPARATOR
Intervention: English version of the query builder
Number of subjects: 42
Study: 25647644

Group type: EXPERIMENTAL
Intervention: Plyometric training (3 times per week for 10 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal training (control group)
Number of subjects: 27
Study: 23456018

Group type: EXPERIMENTAL
Intervention: Patient-specific templates
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 34
Study: 20808072

Group type: EXPERIMENTAL
Intervention: Low intensity exercise (LI): 40% V'O(2)max
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High intensity exercise (HI): 70% V'O(2)max
Number of subjects: 20
Study: 18609044

Group type: EXPERIMENTAL
Intervention: No touch (NT) technique
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional (C) technique
Number of subjects: 93
Study: 16624847

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC; n = 11)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Brisk Walking Group (BWG; n = 8)
Number of subjects: 19
Study: 14707892

Group type: EXPERIMENTAL
Intervention: Computer-assisted insulin dose adjustment
Number of subjects: 10

Group type: COMPARATOR
Intervention: No computer assistance
Number of subjects: 10
Study: 10513041

Group type: EXPERIMENTAL
Intervention: 30 mg PYR
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8558158

Group type: COMPARATOR
Intervention: FVEP P2 latency
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Discriminant function using two ERP and two FVEP component measures
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: FVEP latencies
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: P300 component latency
Number of subjects: 52

Group type: COMPARATOR
Intervention: ERP component (N2/P300) amplitudes or latencies
Number of subjects: 52
Study: 2050326

Group type: EXPERIMENTAL
Intervention: S‐adenosyl‐L‐methionine, 900 mg, administered via daily intravenous infusions for 20 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo administered via daily intravenous infusions for 20 days
Number of subjects: 18
Study: 6402356

Group type: EXPERIMENTAL
Intervention: Anticonvulsant medication (phenobarbitone) during pregnancy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Anticonvulsant medication (multiple agents) during pregnancy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Anticonvulsant medication during pregnancy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Epileptic parents
Number of subjects: 70
Study: 30523758

Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 100 mg/m2 plus gemcitabine 1,000 mg/m2 (arm B)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 125 mg/m2 plus gemcitabine 1,000 mg/m2 (arm D)
Number of subjects: 221
Study: 30661560

Group type: EXPERIMENTAL
Intervention: Intervention condition (universal prevention program)
Number of subjects: 695

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 695
Study: 28092306

Group type: EXPERIMENTAL
Intervention: K(D)PT (pooled group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25901642

Group type: EXPERIMENTAL
Intervention: Keratin gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aqueous cream (Control)
Number of subjects: 20
Study: 24364085

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (500 mL saline solution)
Number of subjects: 200
Study: 22026530

Group type: EXPERIMENTAL
Intervention: Self-forgiveness intervention (4-hour duration)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 79
Study: 19279301

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet
Number of subjects: 63

Group type: COMPARATOR
Intervention: Higher-glycemic index diet (control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet (post-switch)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Obstetric and fetal outcomes
Number of subjects: 63
Study: 16881463

Group type: EXPERIMENTAL
Intervention: Weight-bearing MWM treatment technique
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Non-weight-bearing MWM treatment technique
Number of subjects: 16

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 16
Study: 15747758

Group type: EXPERIMENTAL
Intervention: Small-incision, minimal dissection procedure
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traditional aponeurotic approach
Number of subjects: 72
Study: 11170060

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2B therapy
Number of subjects: 121
Study: 9753190

Group type: EXPERIMENTAL
Intervention: No-go trials (red square presented, subjects instructed not to respond)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Go trials (green square presented, subjects responded by pushing a button)
Number of subjects: 5
Study: 7836111

Group type: EXPERIMENTAL
Intervention: High-carbohydrate (HCHO) diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: High-fat (HFAT) diet
Number of subjects: 9
Study: 2458094

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (intravenous administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride with beta-blocker or serotonin antagonist pretreatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride
Number of subjects: 0
Study: 29391008

Group type: EXPERIMENTAL
Intervention: Home fortification with iron-containing micronutrient powders (two different formulations)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Self-reporting
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Sachet count
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Home fortification with iron-containing micronutrient powders
Number of subjects: 338
Study: 27428280

Group type: EXPERIMENTAL
Intervention: Aerial rope bridge task (stress group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cushion on the ground (control condition)
Number of subjects: 68
Study: 25913828

Group type: EXPERIMENTAL
Intervention: PCV-15
Number of subjects: 60

Group type: COMPARATOR
Intervention: PCV-7
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PCV-15 and PCV-7
Number of subjects: 60
Study: 23275352

Group type: EXPERIMENTAL
Intervention: Liraglutide treatment for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects and subjects with PCOS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 21986347

Group type: EXPERIMENTAL
Intervention: 24‐minute video behavior support intervention with a workbook and 5 sessions of telephone coaching by a trained diabetes nurse
Number of subjects: 201

Group type: COMPARATOR
Intervention: 20‐page brochure developed by the National Diabetes Education Program
Number of subjects: 201
Study: 17681544

Group type: EXPERIMENTAL
Intervention: BRT (capnometry‐assisted breathing therapy)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Delayed‐treatment control group
Number of subjects: 37
Study: 16504907

Group type: EXPERIMENTAL
Intervention: Hands off technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Hands on technique
Number of subjects: 70
Study: 12602447

Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg) administered before daytime sleep
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (lactose-filled capsule)
Number of subjects: 16
Study: 10981531

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide, 500 microg three times per day for 7 days (Group II)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide, 500 microg twice per day for two months (Group III)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Symptomatic treatment only (Group I)
Number of subjects: 117
Study: 8915143

Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium lauryl sulphate (SLS) 1% aqueous solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 1529737

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 7320203

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Behavioral self-control training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 12
Study: 30688550

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (lifestyle changes only)
Number of subjects: 36
Study: 28191264

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Relapse Prevention (MBRP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 63
Study: 26048637

Group type: EXPERIMENTAL
Intervention: Kudzu extract (Alkontrol‐Herbal™) 2g total with an active isoflavone content of 520mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Kudzu extract (Alkontrol‐Herbal™)
Number of subjects: 20
Study: 24028826

Group type: EXPERIMENTAL
Intervention: Internet-based self-management (IBSM) support
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 200
Study: 21899646

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) session
Number of subjects: 20
Study: 18675974

Group type: EXPERIMENTAL
Intervention: Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist
Number of subjects: 10

Group type: COMPARATOR
Intervention: Earlier failed IVF attempts
Number of subjects: 10
Study: 17875180

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study: 16736099

Group type: EXPERIMENTAL
Intervention: Liquid protein substitute
Number of subjects: 27
Study: 14572122

Group type: EXPERIMENTAL
Intervention: Bright light exposure (1,000 lux)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dim light exposure (< 5 lux)
Number of subjects: 16
Study: 11957318

Group type: EXPERIMENTAL
Intervention: Polyester clothing with low moisture absorption and high air permeability (B clothing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cotton clothing with high moisture absorption and high air permeability (C clothing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All three kinds of clothing (A, B, C)
Number of subjects: 0
Study: 7755827

Group type: EXPERIMENTAL
Intervention: Topical lidocaine-epinephrine (TLE)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Tetracaine-adrenaline-cocaine (TAC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: TAC
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: TLE
Number of subjects: 35
Study: 2270298

Group type: EXPERIMENTAL
Intervention: Crystalline penicillin (i.v. infusions for 10 days, daily dose of 20-24 mega U., combined with probenecid, followed by i.m. procaine penicillin in daily dose of 1.2 mega U., total dose 12-50 mega U.)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Procaine penicillin (i.m. in daily dose of 1.2 mega U., total dose 24-60 mega U.)
Number of subjects: 57
Study: 7015539

Group type: EXPERIMENTAL
Intervention: Meptazinol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 0
Study: 31002442

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioural therapy pain management programme (CBT-PMP), six modules delivered once weekly.
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 69
Study: 28339433

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Methadone plus Ketamine
Number of subjects: 42
Study: 26656463

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (2-3 units/day)
Number of subjects: 321

Group type: COMPARATOR
Intervention: 1 or <1 unit/day
Number of subjects: 321

Group type: COMPARATOR
Intervention: Abstinent patients
Number of subjects: 321

Group type: COMPARATOR
Intervention: More than 3 units/day
Number of subjects: 321
Study: 22719022

Group type: EXPERIMENTAL
Intervention: Ticagrelor for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic clopidogrel
Number of subjects: 0
Study: 21694608

Group type: EXPERIMENTAL
Intervention: efavirenz with stavudine + lamivudine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: lamivudine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir
Number of subjects: 68
Study: 18296968

Group type: EXPERIMENTAL
Intervention: 2-minute rest interval group
Number of subjects: 15

Group type: COMPARATOR
Intervention: 4-minute rest interval group
Number of subjects: 15
Study: 16401539

Group type: EXPERIMENTAL
Intervention: U-clips
Number of subjects: 30

Group type: COMPARATOR
Intervention: Suture
Number of subjects: 30
Study: 12741429

Group type: EXPERIMENTAL
Intervention: Estradiol 2 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15635800

Group type: EXPERIMENTAL
Intervention: Administration of 96% ethanol into the cyst after evaluation under ultrasonographic control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple evaluation of the contents of the cyst
Number of subjects: 0
Study: 8775105

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1-3 vol.% (group 1, n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol (group 2, n = 25)
Number of subjects: 50
Study: 1631216

Group type: EXPERIMENTAL
Intervention: Textured implants
Number of subjects: 25

Group type: COMPARATOR
Intervention: Smooth implants
Number of subjects: 25
Study: 6228019

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (n = 17)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: TENS (low-intensity transcutaneous nerve stimulation, n = 18)
Number of subjects: 54

Group type: COMPARATOR
Intervention: TENS-dead battery (placebo, n = 18)
Number of subjects: 54
Study: 31005828

Group type: EXPERIMENTAL
Intervention: Social workers managing LACCL expectations and building relationships by rationing care according to role constraints and sometimes going 'above and beyond' statutory care.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Formal carers conceptualizing care in terms of dedication and discipline.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: LACCL's desire for care that felt familial and went beyond minimum standards.
Number of subjects: 44
Study: 30451774

Group type: EXPERIMENTAL
Intervention: Phone assistance nursing program (3 days per week coaching sessions)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional postoperative management (control group)
Number of subjects: 70
Study: 26955640

Group type: EXPERIMENTAL
Intervention: e-Vita Personal Health Record with Self-Management Support and Coaching
Number of subjects: 132
Study: 24631638

Group type: EXPERIMENTAL
Intervention: PGX(®) 2.5g
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PGX(®) 7.5g
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PGX(®) (7.5g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inulin 5g
Number of subjects: 10
Study: 22143432

Group type: EXPERIMENTAL
Intervention: Beta-alanine (BA)
Number of subjects: 18
Study: 20300914

Group type: EXPERIMENTAL
Intervention: Culturally modified navigator model including both face‐to‐face and telephone formats
Number of subjects: 0
Study: 18157310

Group type: EXPERIMENTAL
Intervention: Spherical orbital implant
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Quad-motility orbital implant
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both spherical and quad-motility orbital implants
Number of subjects: 21
Study: 15329588

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.15 microg x kg(‐1) x min(‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Morphine 0.75 microg x kg(‐1) x min(‐1)
Number of subjects: 40
Study: 11345288

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) nasal spray, 200 microg daily for 2 weeks
Number of subjects: 42
Study: 9202835

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1200 mg/day for 6 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 7526102

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of GSNO starting 10 min before PTCA
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (7 patients receiving standard treatment with aspirin, glyceryl trinitrate, and heparin)
Number of subjects: 13
Study: 3299004

Group type: EXPERIMENTAL
Intervention: Org OD 14 2.5 mg/day
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 28917688

Group type: EXPERIMENTAL
Intervention: mHealth assessment
Number of subjects: 253

Group type: COMPARATOR
Intervention: Standard-care
Number of subjects: 253
Study: 27702766

Group type: EXPERIMENTAL
Intervention: Everolimus-Eluting Stents (EES)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bare-Metal Stents (BMS)
Number of subjects: 64
Study: 25917024

Group type: EXPERIMENTAL
Intervention: Aqueous povidone-iodine solution (Group I)
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Alcoholic povidone-iodine solution (Group II)
Number of subjects: 1326
Study: 23713213

Group type: EXPERIMENTAL
Intervention: Hypobaric exposure (HYPO; 574 mmHg approximately 8000 ft)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normobaric conditions (NORM)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Hypobaric exposure (HYPO)
Number of subjects: 27
Study: 20500100

Group type: EXPERIMENTAL
Intervention: Low-dose polytherapy (metformin 850 mg/day, flutamide 62.5 mg/day, pioglitazone 7.5 mg/day, ethinylestradiol 20 μg/day, drospirenone 3 mg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-dose polytherapy
Number of subjects: 36
Study: 17825587

Group type: EXPERIMENTAL
Intervention: Orthokin
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 167
Study: 16815486

Group type: EXPERIMENTAL
Intervention: Immune-enhancing enteral formula (IEEF) for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular polymeric enteral formula (control group) for 12 weeks
Number of subjects: 30
Study: 12788419

Group type: EXPERIMENTAL
Intervention: Octylcyanoacrylate (OCA)
Number of subjects: 50
Study: 10357340

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 40 mg IM administered 30 min before skin incision (Group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 40 mg IM administered after gallbladder removal (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Chlorpheniramine maleate (CPM) 20 mg IM administered 30 min before skin incision (Control group)
Number of subjects: 90